Some Disappointment Follows Stem Cell Veto


President Bush delighted many conservatives but disappointed medical groups when he vetoed a bill last month that would have expanded federal funding for embryonic stem cell research.

More than 100 groups representing patients, researchers, and physicians backed a bill to overturn tight restrictions on federal funding of embryonic research laid down by the president in August 2001. That decision allowed funding on 77 cell lines already derived at the time, although researchers have since complained that only 20 or so are viable because of contamination and a lack of genetic diversity.

President Bush used the first veto of his presidency to reject the bill (H.R. 810), despite broad bipartisan support in both the House and Senate. Just a day before, the Senate approved the measure 63–37. The House then failed to come close to the two-thirds majority needed to override a veto.

“This bill would support the taking of innocent human life in the hope of finding medical benefits for others. It crosses a moral boundary that our decent society needs to respect, so I vetoed it,” President Bush said in a White House speech. He was flanked by several “Snowflake” children who were adopted while still frozen embryos in fertility clinics.

Bush's move delighted many antiabortion conservatives, who had called on the president to reject the bill.

A handful of states—including California, Massachusetts, and Maryland—have laws funding embryonic stem cell research. Still, advocates of the research warned that the veto would cause the United States to fall behind on a promising therapeutic avenue.

“This research is going to take place. I'd like to see America take a leading role in this,” Lawrence T. Smith, chair of the board of the American Diabetes Association, said in an interview.

Some lawmakers agreed with the president that destroying embryos amounts to ending human life, whereas others, including Sen. Orrin Hatch (R-Utah), concluded that embryos can become human life only if implanted in utero.

Physician lawmakers—most of whom are Republicans—were also split. Rep. Dave Weldon (R-Fla.), an internist, accused supporters of overselling the promise of embryonic stem cells to cure degenerative diseases and spinal cord injuries.

Rep. Weldon was joined by Rep. Phil Gingrey (R-Ga.), an ob.gyn., Rep. Charles W. Boustany Jr. (R-La.), a former cardiac surgeon, and Sen. Tom Coburn, (R-Okla.), a family physician.

Rep. Joe Schwarz (R-Mich.), an otolaryngologist, voted to expand the research. So did Sen. Bill Frist (R-Tenn.), a surgeon, who surprised colleagues last summer when he reversed his support for President Bush and said he'd support overturning research restrictions.

“In all forms of stem cell research, I see today … great promise to heal. Whether it's diabetes, Parkinson's disease, heart disease, Lou Gehrig's disease, or spinal cord injuries, stem cells offer hope for treatment that other lines of research cannot offer,” Sen. Frist said on the Senate floor.

Next Article: